Lyso-GL-3: An important Fabry biomarker associated with adverse clinical outcomes

Biomarkers in Rare Diseases play a dual and significant role in supporting improved clinical outcomes. In Fabry Disease (FD), the glycosphingolipid globotriaosylceramide (Gb3/GL-3) and its… Leer más